Blackrock Health Sciences Trust (BME) Financials

$44.35

$-0.70 (-1.55%)

As on 09-Sep-2026 16:00EDT

Market cap

$589 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

7.7

P/B Ratio

1

Div. Yield

3.4 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Operating Revenue	36.16	24.07	34.90	34.90	-25.97	-25.97
Cost of Revenue	5.63	0.00	6.02	6.02	5.94	5.94
Gross Profit	30.53	24.07	28.87	28.87	-25.97	-25.97
Operating Expenses	-46.46	0.62	0.39	8.85	0.50	0.50
Operating Profit (EBIT)	77.00	23.45	8.46	20.02	-26.47	-26.47
Other Income	--	--	--	--	--	--
Profit before Tax	76.97	23.45	20.02	20.02	-26.47	-26.47
Provision for Tax	--	--	2.01	2.01	1.53	1.53
Profit after Tax (Net Income)	76.97	23.45	20.02	20.02	-26.47	-26.47
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-26.47	-26.47

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Shareholder's Funds	568.30	768.57	588.14	588.14	600.20	600.20
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.83	3.75	7.97	7.97	5.70	0.23
Current Liabilities	--	--	7.96	0.06	0.23	0.23
Total Liabilities	570.14	774.59	596.10	596.10	606.13	606.13

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Non-Current Assets	564.79	549.96	594.40	594.48	606.13	603.68
Current Assets	5.34	26.56	-0.04	1.62	0.00	2.37
Total Assets	570.14	774.59	596.10	596.10	606.13	606.13
Total Debt*	0.89	0.30	0.06	0.06	0.00	0.00
Net Current Assets	--	--	--	--	--	--

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Cash From Operating Activities	-4.35	65.52	32.02	4.76	-0.87	-0.87
Cash Flow from Investing Activities	37.30	66.41	34.78	--	-11.62	--
Cash from Financing Activities	-54.59	-65.52	-32.02	-32.02	0.88	0.88
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Adjusted EPS ($)	5.96	1.77	1.44	--	-1.91	--
Cash EPS ($)	5.96	1.77	1.44	--	-1.91	--
Adjusted Book Value ($)	43.97	57.98	42.18	--	43.30	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.34	4.94	2.30	--	-0.06	--
Free Cash Flow per Share ($)	-0.34	4.94	2.30	--	-0.06	--

Profitability Ratios	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
ROCE (%)	11.50	3.46	3.40	3.37	-4.41	-4.32
ROE (%)	11.51	3.46	3.40	3.37	-4.41	-4.32
ROA (%)	11.45	3.42	3.36	3.33	-4.37	-4.22
EBIT Margin (%)	--	101.50	63.13	63.13	101.93	101.93
Net Margin (%)	212.86	97.44	57.36	57.36	101.93	101.93
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Revenue Growth (%)	0.50	-0.31	2.34	2.34	-1.44	-1.44
EBIT Growth (%)	--	10.90	183.22	183.22	-144.78	-144.78
Net Profit Growth (%)	228.16	17.17	175.62	175.62	-144.78	-144.78
EPS Growth (%)	2.37	0.23	1.75	--	-1.42	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Price / Earnings	6.91	21.44	28.18	--	-22.82	--
Price / Book Value	0.94	0.65	0.96	--	1.01	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	6.85	20.32	26.61	-1.56	-21.92	0.90
Close Price ($)	41.13	37.93	40.46	36.18	43.58	42.44
High Price ($)	41.72	42.86	43.97	45.50	48.78	48.99
Low Price ($)	34.18	36.92	35.53	35.53	38.27	38.27
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	0.00
Current Ratio	--	--	0.00	26.71	0.01	10.16
Quick Ratio	--	--	--	--	0.01	10.16
Interest Coverage	--	313,228.00	400,548.64	400,548.67	--	--

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Oct-23	Dec-22	Oct-22	Dec-21	Oct-21	Dec-20	Oct-20	Dec-19
Debtors to sales (%)	1.18	4.97	4.52	4.52	-9.12	-9.12
Asset Turnover	0.05	0.04	0.06	0.06	-0.04	-0.04
Receivable days	8.20	21.03	16.50	20.65	-33.31	-39.00
Inventory Days	--	--	--	--	--	951.88
Payable days	22.88	2,309,068.36	--	14.15	14.33	390.77
Cash Conversion Cycle	--	--	--	6.50	-47.64	522.11